Denali Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $34M | 1.6M | 21.46 |
| 2023-09-30 | $32M | 1.6M | 20.63 |
| 2023-06-30 | $46M | 1.6M | 29.51 |
| 2023-03-31 | $36M | 1.6M | 23.04 |
| 2022-12-31 | $43M | 1.5M | 27.81 |
| 2022-09-30 | $50M | 1.6M | 30.70 |
| 2022-06-30 | $58M | 2.0M | 29.44 |
| 2022-03-31 | $63M | 2.0M | 32.18 |
| 2021-12-31 | $88M | 2.0M | 44.61 |
| 2021-09-30 | $100M | 2.0M | 50.44 |
| 2021-06-30 | $154M | 2.0M | 78.44 |
| 2021-03-31 | $112M | 2.0M | 57.10 |
| 2020-12-31 | $118M | 1.4M | 83.76 |
| 2020-09-30 | $3.7M | 81k | 45.45 |
| 2020-06-30 | $2.5M | 103k | 24.19 |
| 2020-03-31 | $724k | 41k | 17.52 |
| 2019-12-31 | $734k | 42k | 17.48 |
| 2019-09-30 | $736k | 48k | 15.36 |
| 2019-06-30 | $1.3M | 41k | 31.25 |
| 2019-03-31 | $715k | 46k | 15.62 |
| 2018-12-31 | $689k | 44k | 15.62 |
| 2018-09-30 | $564k | 26k | 21.76 |
| 2018-06-30 | $181k | 12k | 15.16 |